NDC 60505-6177-0 - Busulfan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-6177
- Requested NDC
- 60505-6177-0
- Package NDCs from labels
- 60505-6177-0, 60505-6177-8
- Manufacturer
- Apotex Corp.
- Effective date
- 2022-01-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Busulfan - Apotex Corp. | Apotex Corp. | 2022-01-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-6177-0 | ML - Milliliter | 60505-6177 | 74541e2e-d6af-431f-b0ba-61f481b457d6 | 1 | 2019-09-05 |
| 60505-6177-8 | ML - Milliliter | 60505-6177 | 19950694-cfe4-4fbf-b960-e3e90b2a1878 | 1 | 2019-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Busulfan | BUSULFAN | Sagent Pharmaceuticals | 086a715e-4958-4bb5-9ebd-86171e6b6203 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| MYLERAN | BUSULFAN | Waylis Therapeutics LLC | 2da33e5b-dcfb-4cdf-b163-50398e42f41c | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| Busulfan | BUSULFAN | Eugia US LLC | 06883ac0-4b2a-4f26-89bf-512d37b9ba7f | 2024-06-27 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| Busulfan | BUSULFAN | Accord Healthcare, Inc | fe0ddd44-ef02-4827-b164-7fcbb45bcc1b | 2024-01-05 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| Busulfan | BUSULFAN | Pharmascience Inc. | d0fe44f9-7747-4909-b927-3b24aa6e7e09 | 2022-05-18 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| a0b0bc32-8fc8-8c09-04bf-6a751c60360e | a67d61d4-f985-e653-5343-b49d17784b3c | 2022-01-12 | Boxed warning, Warnings, Adverse reactions | a0b0bc32-8fc8-8c09-04bf-6a751c60360e a67d61d4-f985-e653-5343-b49d17784b3c | ||
| BUSULFAN | BUSULFAN | Hospira, Inc. | b9c7f0dc-988d-466e-8031-400ec4f60f21 | 2021-08-09 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| Busulfan | BUSULFAN | Meitheal Pharmaceuticals Inc. | dc384f16-4e25-458e-874c-553f81c6d8c9 | 2021-06-14 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| Busulfan | BUSULFAN | Meitheal Pharmaceuticals Inc. | 6e68ab21-19bd-4b7e-b8d0-bf284d5af183 | 2021-06-14 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| Busulfan | BUSULFAN | Amneal Pharmaceuticals LLC | ac9448da-37ad-4609-9aef-eedf8be0f69c | 2020-09-23 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.